Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
1.990
0.00 (0.00%)
At close: Jan 17, 2025, 4:00 PM
2.020
+0.030 (1.51%)
After-hours: Jan 17, 2025, 6:56 PM EST
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $199.65 million as of January 17, 2025. Its market cap has decreased by -73.19% in one year.
Market Cap
199.65M
Enterprise Value
-355.34M
1-Year Change
-73.19%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $199.65M, a decrease of -88.04%. That is a compound annual growth rate of -71.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 199.65M | -36.62% |
| Dec 31, 2024 | 315.02M | -56.62% |
| Dec 29, 2023 | 726.15M | -56.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |